Supriya Lifescience Limited (SUPRIYA) - Total Liabilities

Latest as of September 2025: Rs1.21 Billion INR ≈ $13.10 Million USD

Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has total liabilities worth Rs1.21 Billion INR (≈ $13.10 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Supriya Lifescience Limited's assets to evaluate the company's liquid asset resilience ratio.

Supriya Lifescience Limited - Total Liabilities Trend (2018–2025)

This chart illustrates how Supriya Lifescience Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SUPRIYA asset base.

Supriya Lifescience Limited Competitors by Total Liabilities

The table below lists competitors of Supriya Lifescience Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Shenzhen INVT Electric Co Ltd SHE:002334	China	CN¥3.10 Billion
Asiainfo Security Technologies Corp. A SHG:688225	China	CN¥5.68 Billion
Shanghai Zhongyida Co Ltd A SHG:600610	China	CN¥926.04 Million
Yieh Phui Enterprise Co Ltd TW:2023	Taiwan	NT$66.43 Billion
Forward Industries Inc NASDAQ:FORD	USA	$4.82 Million
Shanghai Research Institute of Building Sciences Group Co. Ltd A SHG:603153	China	CN¥1.77 Billion
Hunan Jingfeng Pharmaceutical SHE:000908	China	CN¥915.74 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Supriya Lifescience Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Supriya Lifescience Limited (SUPRIYA) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Supriya Lifescience Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Supriya Lifescience Limited (2018–2025)

The table below shows the annual total liabilities of Supriya Lifescience Limited from 2018 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs1.16 Billion ≈ $12.50 Million	+9.15%
2024-03-31	Rs1.06 Billion ≈ $11.45 Million	-12.37%
2023-03-31	Rs1.21 Billion ≈ $13.07 Million	+1.46%
2022-03-31	Rs1.19 Billion ≈ $12.88 Million	-32.68%
2021-03-31	Rs1.77 Billion ≈ $19.13 Million	-5.53%
2020-03-31	Rs1.87 Billion ≈ $20.25 Million	+17.57%
2019-03-31	Rs1.59 Billion ≈ $17.22 Million	-16.50%
2018-03-31	Rs1.91 Billion ≈ $20.63 Million	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$788.84 Million

Rs72.94 Billion INR

Market Cap Rank

#10043 Global

#499 in India

Share Price

Rs906.30

Change (1 day)

+0.63%

52-Week Range

Rs553.35 - Rs1052.50

All Time High

Rs1052.50